Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Carnitine, carnitine acyltransferases, and rat brain function
Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge
Sadly, yes
doi:10.1124/jpet.111.182220
FOXO4-DRI vs nearby senolytics Option FOXO4-DRI Type D-retro-inverso peptide Human trial stage None (preclinical only) Option Dasatinib + Quercetin (D+Q) Type Small-molecule drug + flavonoid Human trial stage Early human trials (e.g., Alzheimer's) Option Navitoclax Type BCL-2 family inhibitor Human trial stage Later-stage trials (e.g., myelofibrosis) D+Q and navitoclax are further along in humans but can affect healthy cells (e.g., low platelets)
US$ 25.48
US$ 28.80
US$ 21.19
US$ 26.41
US$ 28.29
US$ 25.31
US$ 28.07
US$ 29.45
